Chemoinformaics analysis of 3-ACETYL-4-HYDROXY-6-PHENYL-2H-PYRAN-2-ONE
| Molecular Weight | 230.219 | nRot | 2 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 14 |
| Exact Molecular Weight | 230.058 | nRing | 2 |
| Solubility: LogS | -3.047 | nHRing | 1 |
| Solubility: LogP | 2.394 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 31.5859 |
| nHD | 1 | BPOL | 13.5041 |
| QED | 0.803 |
| Synth | 2.084 |
| Natural Product Likeliness | 0.474 |
| NR-PPAR-gamma | 0.286 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.162 |
| Pgp-sub | 0.083 |
| HIA | 0.007 |
| CACO-2 | -4.708 |
| MDCK | 0.0000178 |
| BBB | 0.038 |
| PPB | 0.952543 |
| VDSS | 0.502 |
| FU | 0.0301936 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.596 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.581 |
| CYP2c9-sub | 0.875 |
| CYP2d6-inh | 0.162 |
| CYP2d6-sub | 0.433 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.156 |
| CL | 1.104 |
| T12 | 0.399 |
| hERG | 0.111 |
| Ames | 0.032 |
| ROA | 0.2 |
| SkinSen | 0.351 |
| Carcinogencity | 0.453 |
| EI | 0.899 |
| Respiratory | 0.757 |
| NR-Aromatase | 0.033 |
| Antiviral | No |
| Prediction | 0.710596 |